Skip to main content
Top
Published in: Strahlentherapie und Onkologie 10/2014

01-10-2014 | Case study

FET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma

First tolerability and feasibility results

Authors: Angelika Bilger, Martin-Immanuel Bittner, Anca-L. Grosu, Nicole Wiedenmann, Philipp T. Meyer, Elke Firat, Gabriele Niedermann, Wolfgang A. Weber, Dr. Dušan Milanović

Published in: Strahlentherapie und Onkologie | Issue 10/2014

Login to get access

Abstract

Background

Treatment of recurrent glioblastoma (rGBM) remains an unsolved clinical problem. Reirradiation (re-RT) can be used to treat some patients with rGBM, but as a monotherapy it has only limited efficacy. Chloroquine (CQ) is an anti-malaria and immunomodulatory drug that may inhibit autophagy and increase the radiosensitivity of GBM.

Patients and methods

Between January 2012 and August 2013, we treated five patients with histologically confirmed rGBM with re-RT and 250 mg CQ daily.

Results

Treatment was very well tolerated; no CQ-related toxicity was observed. At the first follow-up 2 months after finishing re-RT, two patients achieved partial response (PR), one patient stable disease (SD), and one patient progressive disease (PD). One patient with reirradiated surgical cavity did not show any sign of PD.

Conclusion

In this case series, we observed encouraging responses to CQ and re-RT. We plan to conduct a CQ dose escalation study combined with re-RT.
Literature
1.
go back to reference Eldredge HB, Denittis A, Duhadaway JB et al (2013) Concurrent whole brain radiotherapy and short-course chloroquine in patients with brain metastases: a pilot trial. J Radiation Oncol 315–321 Eldredge HB, Denittis A, Duhadaway JB et al (2013) Concurrent whole brain radiotherapy and short-course chloroquine in patients with brain metastases: a pilot trial. J Radiation Oncol 315–321
2.
go back to reference Firat E, Weyerbrock A, Gaedicke S et al (2012) Chloroquine or chloroquine-PI3K/Akt pathway inhibitor combinations strongly promote gamma-irradiation-induced cell death in primary stem-like glioma cells. PLoS One 7:e47357PubMedCrossRefPubMedCentral Firat E, Weyerbrock A, Gaedicke S et al (2012) Chloroquine or chloroquine-PI3K/Akt pathway inhibitor combinations strongly promote gamma-irradiation-induced cell death in primary stem-like glioma cells. PLoS One 7:e47357PubMedCrossRefPubMedCentral
3.
go back to reference Fokas E, Wacker U, Gross MW et al (2009) Hypofractionated stereotactic reirradiation of recurrent glioblastomas: a beneficial treatment option after high-dose radiotherapy? Strahlenther Onkol 185:235–240PubMedCrossRef Fokas E, Wacker U, Gross MW et al (2009) Hypofractionated stereotactic reirradiation of recurrent glioblastomas: a beneficial treatment option after high-dose radiotherapy? Strahlenther Onkol 185:235–240PubMedCrossRef
4.
go back to reference Grosu AL, Lachner R, Wiedenmann N et al (2003) Validation of a method for automatic image fusion (BrainLAB System) of CT data and 11C-methionine-PET data for stereotactic radiotherapy using a LINAC: first clinical experience. Int J Radiat Oncol Biol Phys 56:1450–1463PubMedCrossRef Grosu AL, Lachner R, Wiedenmann N et al (2003) Validation of a method for automatic image fusion (BrainLAB System) of CT data and 11C-methionine-PET data for stereotactic radiotherapy using a LINAC: first clinical experience. Int J Radiat Oncol Biol Phys 56:1450–1463PubMedCrossRef
5.
go back to reference Grosu AL, Weber WA, Franz M et al (2005) Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 63:511–519PubMedCrossRef Grosu AL, Weber WA, Franz M et al (2005) Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 63:511–519PubMedCrossRef
6.
go back to reference Hu YL, DeLay M, Jahangiri A et al (2012) Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma. Cancer Res 72:1773–1783PubMedCrossRefPubMedCentral Hu YL, DeLay M, Jahangiri A et al (2012) Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma. Cancer Res 72:1773–1783PubMedCrossRefPubMedCentral
7.
go back to reference Kim EL, Wüstenberg R, Rübsam A et al (2010) Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells. Neuro Oncol 12:389–400PubMedCrossRefPubMedCentral Kim EL, Wüstenberg R, Rübsam A et al (2010) Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells. Neuro Oncol 12:389–400PubMedCrossRefPubMedCentral
8.
go back to reference Kim SY, Yoo YH, Park JW (2013) Silencing of mitochondrial NADP(+)-dependent isocitrate dehydrogenase gene enhances glioma radiosensitivity. Biochem Biophys Res Commun 433:260–265PubMedCrossRef Kim SY, Yoo YH, Park JW (2013) Silencing of mitochondrial NADP(+)-dependent isocitrate dehydrogenase gene enhances glioma radiosensitivity. Biochem Biophys Res Commun 433:260–265PubMedCrossRef
9.
go back to reference Liu WM, Huang P, Kar N et al (2013) Lyn facilitates glioblastoma cell survival under conditions of nutrient deprivation by promoting autophagy. PLoS One 8:e70804PubMedCrossRefPubMedCentral Liu WM, Huang P, Kar N et al (2013) Lyn facilitates glioblastoma cell survival under conditions of nutrient deprivation by promoting autophagy. PLoS One 8:e70804PubMedCrossRefPubMedCentral
10.
go back to reference Mizumoto M, Okumura T, Ishikawa E et al (2013) Reirradiation for recurrent malignant brain tumor with radiotherapy or proton beam therapy. Technical considerations based on experience at a single institution. Strahlenther Onkol 189:656–663PubMedCrossRef Mizumoto M, Okumura T, Ishikawa E et al (2013) Reirradiation for recurrent malignant brain tumor with radiotherapy or proton beam therapy. Technical considerations based on experience at a single institution. Strahlenther Onkol 189:656–663PubMedCrossRef
12.
go back to reference Munshi A, Kakkar S, Budrukkar A, Jalali R (2008). Unusual intensification of skin reactions by chloroquine use during breast radiotherapy. Acta Oncol 47:318–319PubMedCrossRef Munshi A, Kakkar S, Budrukkar A, Jalali R (2008). Unusual intensification of skin reactions by chloroquine use during breast radiotherapy. Acta Oncol 47:318–319PubMedCrossRef
13.
go back to reference Noda SE, El-Jawahri A, Patel D et al (2009). Molecular advances of brain tumors in radiation oncology. Semin Radiat Oncol 19:171–178PubMedCrossRef Noda SE, El-Jawahri A, Patel D et al (2009). Molecular advances of brain tumors in radiation oncology. Semin Radiat Oncol 19:171–178PubMedCrossRef
14.
go back to reference Palumbo S, Comincini S (2013). Autophagy and ionizing radiation in tumors: the “survive or not survive” dilemma. J Cell Physiol 228:1–8PubMedCrossRef Palumbo S, Comincini S (2013). Autophagy and ionizing radiation in tumors: the “survive or not survive” dilemma. J Cell Physiol 228:1–8PubMedCrossRef
15.
go back to reference Rojas-Puentes LL, Gonzalez-Pinedo M, Crismatt A et al (2013) Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases. Radiat Oncol 8:209PubMedCrossRefPubMedCentral Rojas-Puentes LL, Gonzalez-Pinedo M, Crismatt A et al (2013) Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases. Radiat Oncol 8:209PubMedCrossRefPubMedCentral
16.
go back to reference Rustogi A, Munshi A, Jalali R (2006) Unexpected skin reaction induced by radiotherapy after chloroquine use. Lancet Oncol 7:608–609PubMedCrossRef Rustogi A, Munshi A, Jalali R (2006) Unexpected skin reaction induced by radiotherapy after chloroquine use. Lancet Oncol 7:608–609PubMedCrossRef
17.
go back to reference Sotelo J, Briceno E, Lopez-Gonzalez MA (2006) Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 144:337–343PubMedCrossRef Sotelo J, Briceno E, Lopez-Gonzalez MA (2006) Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 144:337–343PubMedCrossRef
18.
go back to reference Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996PubMedCrossRef Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996PubMedCrossRef
19.
go back to reference Utley JF, Sachatello CR, Maruyama Y et al (1977) Radiosensitization of normal tissue by chloroquine. Radiology 124:255–257PubMedCrossRef Utley JF, Sachatello CR, Maruyama Y et al (1977) Radiosensitization of normal tissue by chloroquine. Radiology 124:255–257PubMedCrossRef
Metadata
Title
FET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma
First tolerability and feasibility results
Authors
Angelika Bilger
Martin-Immanuel Bittner
Anca-L. Grosu
Nicole Wiedenmann
Philipp T. Meyer
Elke Firat
Gabriele Niedermann
Wolfgang A. Weber
Dr. Dušan Milanović
Publication date
01-10-2014
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 10/2014
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-014-0693-2

Other articles of this Issue 10/2014

Strahlentherapie und Onkologie 10/2014 Go to the issue

Mitteilungen der Fachgesellschaften

Mitteilungen der Fachgesellschaften